Overview
NICE is unable to recommend the use in the NHS of carmustine implants as an adjunct to surgery in patients with recurrent glioblastoma multiforme for whom surgical resection is indicated because no evidence submission was received from the manufacturer or sponsor of the technology.
Last reviewed: 24 June 2008
Next review: We will review this decision if the company decides to make a submission.